Tetracore is a biotechnology research and development organization that develops highly innovative kits, assays and reagents for the detection of infectious diseases, biological warfare (BW) threat agents and biological markers. The company focuses on antibody-based and nucleic acid-based detection reagents and technologies. Tetracore offers a broad range of highly-specific, rapid, antibody-based test kits and antibody reagents for the detection of BW infectious agents and toxins, including the first FDA cleared test kit for identification of B. anthracis from colonies. Tetracore also offers a product line of real-time, probe hydrolysis Polymerase Chain Reaction (PCR) tests for animal pathogens. In addition, Tetracore contracts with the US Government for development of: real-time PCR diagnostic tests for BW agents, novel nucleic acid extraction procedures, and specialized nucleic acid products.
The four founding scientists, Gary Long, Ph. D., Beverly L. Mangold, Ph.D.*, Thomas W. O'Brien, Ph.D., and William M. Nelson, M.D. (CDR, US Navy Ret.), have been leaders in the development of state-of-the-art diagnostic technology for use by the Joint Program Office for Bio-defense (JPO), the Department of Defense (DOD), FBI, and DOE. These scientists bring their extensive expertise and skills to Tetracore Inc. in order to provide these same organizations with an expanded production capability, greater flexibility in the development of new technology, and the ability to innovate in an entrepreneurial atmosphere.
Tetracore's strong scientific team and powerful technology base positions the company at the forefront in the development and production of today's important detection tools for Clinical, Animal Health, and Domestic Preparedness Testing.
